Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Future perspectives for cryptococcosis treatment.

Santos-Gandelman J, Rodrigues ML, Machado Silva A.

Expert Opin Ther Pat. 2018 Aug;28(8):625-634. doi: 10.1080/13543776.2018.1503252. Epub 2018 Aug 7. Review.

PMID:
30084284
2.

Molecular modeling studies of coruscanone (A) core nucleus as potential antifungal agents.

Khan H, Sabbah DA, Zafar M, Mubarak MS.

Life Sci. 2018 Sep 15;209:332-340. doi: 10.1016/j.lfs.2018.07.059. Epub 2018 Aug 1. Review.

PMID:
30076924
3.

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda.

Lofgren SM, Nalintya E, Meya DB, Boulware DR, Rajasingham R.

Medicine (Baltimore). 2018 Aug;97(31):e11722. doi: 10.1097/MD.0000000000011722.

4.

Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.

Brito AC, Bittencourt MJS.

An Bras Dermatol. 2018 Jul-Aug;93(4):495-506. doi: 10.1590/abd1806-4841.20187321. Review.

5.

Treatment for HIV-associated cryptococcal meningitis.

Tenforde MW, Shapiro AE, Rouse B, Jarvis JN, Li T, Eshun-Wilson I, Ford N.

Cochrane Database Syst Rev. 2018 Jul 25;7:CD005647. doi: 10.1002/14651858.CD005647.pub3. Review.

PMID:
30045416
6.

Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.

Eshun-Wilson I, Okwen MP, Richardson M, Bicanic T.

Cochrane Database Syst Rev. 2018 Jul 24;7:CD009012. doi: 10.1002/14651858.CD009012.pub3. Review.

PMID:
30039850
7.

Bioequivalence study of two formulations of itraconazole 100 mg capsules in healthy volunteers under fed conditions: a randomized, three-period, reference-replicated, crossover study.

Dragojević-Simić V, Kovačević A, Jaćević V, Rančić N, Djordjević S, Kilibarda V, Mikov M, Bokonjić D.

Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):979-988. doi: 10.1080/17425255.2018.1503649. Epub 2018 Aug 1.

PMID:
30028640
8.

Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system.

Stott KE, Hope W.

Expert Opin Drug Metab Toxicol. 2018 Aug;14(8):803-815. doi: 10.1080/17425255.2018.1492551. Epub 2018 Jul 9. Review.

PMID:
29943650
9.

Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.

Pasternak B, Wintzell V, Furu K, Engeland A, Neovius M, Stephansson O.

JAMA. 2018 Jun 12;319(22):2333-2335. doi: 10.1001/jama.2018.6237. No abstract available.

PMID:
29896619
10.

Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.

Yeaman MR, Büttner S, Thevissen K.

Oxid Med Cell Longev. 2018 Apr 26;2018:5473817. doi: 10.1155/2018/5473817. eCollection 2018. Review.

11.

Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient Safety.

Greenblatt DJ, Harmatz JS, Ryan MJ, Chow CR.

J Clin Psychopharmacol. 2018 Aug;38(4):289-295. doi: 10.1097/JCP.0000000000000892.

PMID:
29851709
12.

Comparison of serum PCT and CRP levels in patients infected by different pathogenic microorganisms: a systematic review and meta-analysis.

Tang JH, Gao DP, Zou PF.

Braz J Med Biol Res. 2018;51(7):e6783. doi: 10.1590/1414-431x20176783. Epub 2018 May 28. Review.

13.

Progress on the Antimicrobial Activity Research of Clove Oil and Eugenol in the Food Antisepsis Field.

Hu Q, Zhou M, Wei S.

J Food Sci. 2018 Jun;83(6):1476-1483. doi: 10.1111/1750-3841.14180. Epub 2018 May 26. Review.

PMID:
29802735
14.

Interface Fungal Keratitis After Descemet Stripping Automated Endothelial Keratoplasty: A Review of the Literature With a Focus on Outcomes.

McElnea E, Power B, Murphy C.

Cornea. 2018 Sep;37(9):1204-1211. doi: 10.1097/ICO.0000000000001636. Review.

PMID:
29781928
15.

Worldwide emergence of resistance to antifungal drugs challenges human health and food security.

Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ.

Science. 2018 May 18;360(6390):739-742. doi: 10.1126/science.aap7999. Review.

16.

Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.

Slack MA, Thomsen IP.

J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S25-S30. doi: 10.1093/jpids/piy016. Review.

17.

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.

Chammard TB, Temfack E, Lortholary O, Alanio A.

Mem Inst Oswaldo Cruz. 2018;113(7):e180050. doi: 10.1590/0074-02760180050. Epub 2018 May 7. Review.

18.

Fusarium: The versatile pathogen.

Tupaki-Sreepurna A, Kindo AJ.

Indian J Med Microbiol. 2018 Jan-Mar;36(1):8-17. doi: 10.4103/ijmm.IJMM_16_24. Review.

19.

Imaging paracoccidioidomycosis: A pictorial review from head to toe.

Rosa Júnior M, Baldon IV, Amorim AFC, Fonseca APA, Volpato R, Lourenço RB, Baptista RM, de Mello RAF, Peçanha P, Falqueto A.

Eur J Radiol. 2018 Jun;103:147-162. doi: 10.1016/j.ejrad.2018.03.026. Epub 2018 Mar 31. Review.

PMID:
29685479
20.

Variability in innate host immune responses to cryptococcosis.

Garelnabi M, May RC.

Mem Inst Oswaldo Cruz. 2018;113(7):e180060. doi: 10.1590/0074-02760180060. Epub 2018 Apr 16. Review.

Supplemental Content

Loading ...
Support Center